EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse

Ofer Nativ, Eilata Dalal, Guy Hidas*, Moshe Aronson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Aim: The aim of this study was to determine the effect of intravesical EDTA instillation on the development of intravesically implanted tumor cells in normal mice. Methods: The mouse bladder tumor (MBT-2) model was used in female C3H/eb mice to evaluate the amount of normal urothelial cell shedding, and the degree of tumor growth inhibition following intravesical EDTA instillation in comparison with phosphate-buffered saline (PBS) instillation. Results: At 1 h after instillation, the number of urothelial cells aspirated was 500-1000 per PBS-treated mouse and 10 000-20 000 per EDTA-treated mouse (P < 0.00001). The bladder weight, which reflected the effect of the agent on the tumor, was similar in the untreated and PBS-treated mice (105.46 ± 46 mg and 106.2 ± 50 mg, respectively). It was significantly lower in the EDTA-treated mice (80.4 ± 42 mg) (P = 0.0045). Conclusions: Intravesical administration of EDTA results in significant normal and neoplastic urothelial cell shedding. Intravesical irrigation with EDTA may prevent adherence of the malignant cells to the bladder wall following tumor resection.

Original languageEnglish
Pages (from-to)1344-1346
Number of pages3
JournalInternational Journal of Urology
Issue number10
StatePublished - Oct 2006


  • Bladder cancer
  • EDTA
  • Mouse
  • Treatment


Dive into the research topics of 'EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse'. Together they form a unique fingerprint.

Cite this